What Johnson & Johnson Impact Ventures does

Johnson & Johnson Impact Ventures is a wholly-owned corporate impact investment subsidiary of Johnson & Johnson (NYSE: JNJ), founded in 2019 and headquartered in New Brunswick, United States. The fund invests in purpose-driven entrepreneurs innovating at the front lines of healthcare delivery, with a thematic focus on improving access and outcomes in underserved markets across Africa, the Middle East, and other emerging regions. Its portfolio spans clinic-based primary care (e.g., Penda Health, which provides maternal and child health services in Kenya and delivers quarterly impact reports under a formalized impact measurement and management framework) and AI-enabled digital health (e.g., Rology, an AI-assisted teleradiology platform serving over 300 hospitals across 13 countries, in whose November 2025 growth round J&J Impact Ventures participated alongside Philips Foundation, Sanofi Global Health Unit's Impact Fund, and MIT Solve Innovation Future).

The entity operates with a small team of 1-10 employees and functions as a strategic capital deployment arm of Johnson & Johnson rather than a standalone revenue-generating business. Its core "product" is equity investment combined with the credibility and resources of the J&J parent, including access to the parent's global healthcare network, brand equity, and emerging-market presence. Deal flow and portfolio support are reinforced by a recurring multi-investor syndicate structure, positioning the fund as a co-investor of choice for other major healthcare-aligned impact investors (Philips Foundation, Sanofi Global Health Unit, MIT Solve). There is no disclosed pricing model, external fund-raising, or management-fee structure; capital is sourced internally from Johnson & Johnson.

Input data does not disclose AUM, portfolio company count, ticket sizes, or geographic restrictions, and the fund's own website was inaccessible at the time of capture (returning a maintenance error). The investment thesis appears consistent with J&J's broader global health and environmental, social, and governance (ESG) commitments, emphasizing measurable health outcomes — particularly maternal/child health and healthcare workforce shortages (radiology) — rather than financial returns maximization.

Name

Johnson & Johnson Impact Ventures

Website

https://impactventures.jnj.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Johnson & Johnson Impact Ventures is the corporate impact investment arm of Johnson & Johnson, funding purpose-driven healthcare startups serving underserved markets in regions such as East Africa and the Middle East. The New Brunswick-based fund deploys capital into portfolio companies across digital health and primary care since 2019.

Ownership category

akta.pro rank

Product category

Impact Investment / Venture Capital

NAICS

Portfolio Management and Investment Advice (52394)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

akta.pro secondary industries

Impact / ESG Venture Capital (FSANAAAG), Impact Investment & Development Investment Funds (BPADACAO)

Keywords

• Impact investing
• Venture capital
• Healthcare investments
• Social impact funds
• Startup funding

Headquarters

HQ city

New Brunswick

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Core offering

Johnson & Johnson Impact Ventures is an impact investment initiative of Johnson & Johnson that deploys capital into purpose-driven healthcare entrepreneurs and startups operating at the front lines of care. The fund participates in growth funding rounds of companies addressing healthcare access gaps in underserved markets, co-investing alongside other strategic healthcare investors such as Philips Foundation and Sanofi Global Health Unit's Impact Fund.

Product overview

Johnson & Johnson Impact Ventures is an impact investment initiative that provides funding and support to healthcare startups in underserved markets. The available source data focuses on investment recipients (such as Rology and Penda Health) rather than describing Johnson & Johnson Impact Ventures' own product portfolio or service offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Impact Investment Capital
• Portfolio Impact Measurement and Management

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights4 records

Direct peers

• Sanofi Global Health Unit's Impact Fund: Co-invested alongside J&J Impact Ventures in Rology's 2025 growth round. Both are corporate-backed impact funds focused on expanding healthcare access in underserved markets, with comparable mandates and co-investment behavior.
• Philips Foundation: Co-led Rology's 2025 growth round with J&J Impact Ventures. Philips Foundation is the impact investing arm of Royal Philips, focused on healthcare access through technology-enabled solutions, making it a directly comparable corporate impact fund.
• Novartis Foundation: Novartis's philanthropic and impact arm focuses on expanding access to healthcare in low- and middle-income countries. Closely comparable as a Big Pharma-backed healthcare impact investor with similar global health access mandate.
• Merck Global Health Innovation Fund: Merck's venture arm invests in digital health and global health innovation. Comparable as a major pharma corporate investor with healthcare-focused portfolio strategy.
• Boehringer Ingelheim Social Engagement: Boehringer Ingelheim's impact and social engagement programs invest in access-to-healthcare initiatives in underserved regions. Comparable as another large pharma corporate impact investor addressing healthcare access gaps.
• Bayer Foundation: Bayer's philanthropic and impact arm invests in health and nutrition innovations globally. Comparable as another large-cap healthcare company's corporate impact investor with similar global health access mandate.
• Medtronic Foundation: Medtronic's philanthropic arm invests in expanding access to healthcare technology and chronic disease management. Comparable as a medtech corporate impact investor with global health access focus.
• GSK Impact Investments: GSK's impact investing initiatives fund healthcare access and innovation in underserved markets. Comparable as a major pharma corporate impact investor with global health mandate.

Broad incumbents

• Acumen: Acumen is a pioneering impact investment fund focused on poverty alleviation including healthcare access across Africa and South Asia. Comparable as a larger, more established impact investor in healthcare access for underserved markets.
• PATH: PATH is a global health organization that invests in and accelerates healthcare innovations for low-resource settings. Comparable as a larger, established global health innovation investor with similar mission.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/JNJGlobalHealth

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johnson & Johnson Impact Ventures